Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative
Read moreHome »
FDA Approves New Eylea (aflibercept) Injection Dosing Schedule in Wet Age-Related Macular Degeneration
TARRYTOWN, N.Y., Aug. 17, 2018 /PRNewswire/ — Regeneron Pharmaceuticals, Inc.
Read more